Please login to the form below

Aimvog

This page shows the latest Aimvog news and features for those working in and with pharma, biotech and healthcare.

Suggests clinicians should confirm that patients have tried other therapies prior to using CGRP inhibitors

More from news
Approximately 3 fully matching, plus 0 partially matching documents found.

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Client Services Director – Medical Education Agency – North West...: Salary TBC

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Add my company

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

What is blockchain and why should i care - Richard Springham: Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone: Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...
Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?: What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...